Clinical Trial Update: Heparin or Enoxaparin in Patients With Cancer

View source ↗

Summary

A completed clinical trial evaluated the use of heparin versus enoxaparin in cancer patients to assess outcomes related to thrombosis and cancer-associated comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Thromboembolism
• Unspecified Adult Solid Tumor

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma, Thromboembolism | Status: COMPLETED